[Community-acquired pneumonia in adults]

Area of Science:

• Infectious Diseases
• Pulmonology
• Clinical Guidelines

Background:

• Community-acquired pneumonia (CAP) is a leading global infectious disease.
• High morbidity and mortality rates necessitate effective management strategies.
• Current German recommendations for CAP management are reviewed.

Purpose of the Study:

• To summarize current recommendations for managing CAP in Germany.
• To highlight the importance of risk stratification and individualized therapy.
• To provide guidance on antibiotic selection, administration, and duration.

Main Methods:

• Review of current clinical guidelines and recommendations for CAP management in Germany.
• Discussion of risk stratification tools, including the DS-CRB-65 Score and ATS/IDSA criteria.
• Summary of principles for antibiotic therapy selection, adjustment, and duration.

Main Results:

• CAP management is patient-risk-based, utilizing tools like the DS-CRB-65 Score.
• Initial antibiotic therapy targets expected pathogens, with adjustments based on patient response.
• Intravenous administration is common for inpatients; bioavailability is key for oral therapy.

Conclusions:

• A mandatory reevaluation within 48-72 hours is crucial for effective CAP management.
• A typical therapy duration of 5-7 days is generally sufficient.
• Preventive measures like vaccinations and smoking cessation are vital for reducing CAP incidence.